A detailed history of Teacher Retirement System Of Texas transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 34,078 shares of AUPH stock, worth $306,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,078
Previous 30,169 12.96%
Holding current value
$306,020
Previous $172,000 44.77%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.32 - $7.33 $20,795 - $28,652
3,909 Added 12.96%
34,078 $249,000
Q2 2024

Aug 09, 2024

SELL
$4.81 - $5.78 $923 - $1,109
-192 Reduced 0.63%
30,169 $172,000
Q1 2024

May 06, 2024

SELL
$4.93 - $9.31 $5,713 - $10,790
-1,159 Reduced 3.68%
30,361 $152,000
Q4 2023

Feb 07, 2024

SELL
$7.13 - $9.49 $50,694 - $67,473
-7,110 Reduced 18.41%
31,520 $283,000
Q3 2023

Oct 31, 2023

BUY
$7.77 - $12.27 $29,836 - $47,116
3,840 Added 11.04%
38,630 $300,000
Q2 2023

Jul 19, 2023

SELL
$8.96 - $11.69 $21,692 - $28,301
-2,421 Reduced 6.51%
34,790 $337,000
Q1 2023

May 12, 2023

BUY
$5.94 - $11.27 $4,817 - $9,139
811 Added 2.23%
37,211 $408,000
Q4 2022

Feb 10, 2023

SELL
$4.11 - $8.14 $12,580 - $24,916
-3,061 Reduced 7.76%
36,400 $157,000
Q3 2022

Nov 03, 2022

BUY
$6.66 - $12.39 $145,514 - $270,709
21,849 Added 124.06%
39,461 $297,000
Q2 2022

Aug 09, 2022

SELL
$8.95 - $12.8 $46,405 - $66,368
-5,185 Reduced 22.74%
17,612 $177,000
Q1 2022

May 09, 2022

SELL
$10.05 - $22.48 $987,131 - $2.21 Million
-98,222 Reduced 81.16%
22,797 $282,000
Q4 2021

Feb 10, 2022

BUY
$17.78 - $33.08 $1.85 Million - $3.45 Million
104,215 Added 620.18%
121,019 $2.77 Million
Q3 2021

Nov 09, 2021

BUY
$10.93 - $23.55 $183,667 - $395,734
16,804 New
16,804 $372,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.27B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.